{"id":8513,"date":"2017-08-02T07:36:32","date_gmt":"2017-08-02T07:36:32","guid":{"rendered":"https:\/\/www.rootsanalysis.com\/blog\/?p=8513"},"modified":"2026-07-09T15:28:37","modified_gmt":"2026-07-09T09:58:37","slug":"t-cell-immunotherapy-the-next-big-thing-in-immunotherapeutics","status":"publish","type":"post","link":"https:\/\/www.rootsanalysis.com\/blog\/t-cell-immunotherapy-the-next-big-thing-in-immunotherapeutics\/","title":{"rendered":"T-Cell Immunotherapy: The Next Big Thing in Immunotherapeutics"},"content":{"rendered":"<div class=\"wp-block-image\">\n<figure class=\"alignleft\"><img loading=\"lazy\" decoding=\"async\" width=\"150\" height=\"150\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2017\/08\/44667192_m-150x150.jpg\" alt=\"T-Cell Immunotherapy\" class=\"wp-image-8521\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2017\/08\/44667192_m-150x150.jpg 150w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2017\/08\/44667192_m-180x180.jpg 180w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2017\/08\/44667192_m-300x300.jpg 300w\" sizes=\"auto, (max-width: 150px) 100vw, 150px\" \/><\/figure>\n<\/div>\n\n\n<p class=\"wp-block-paragraph\">The concept of immunotherapies dates back to the 18th century; however, since its inception, the field has evolved tremendously&nbsp;and is currently cited as one of the most rapidly growing segments of the pharmaceutical industry. Post the early success of immune checkpoint inhibitors, T-cell immunotherapy has emerged as another innovative and potent arm of this market. &nbsp;The <strong>&#8216;<a href=\"https:\/\/www.rootsanalysis.com\/reports\/t-cell-therapies-market\/261.html\">T-Cell Immunotherapy Market, 2017-2030 (2<span style=\"font-size: 13.3333px;\">nd<\/span> edition)<\/a>&#8216;<\/strong><em>&nbsp;<\/em>report features an extensive study of the current market landscape and the future potential of T-cell immunotherapies. Mentioned below are a few key takeaways from the report.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Rising Popularity on Social Media:<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Popularity on social media portals, such as Twitter, demonstrate the growing importance of T-cell immunotherapies<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"672\" height=\"420\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/T-Cell-Immunotherapy-Social-Media-Trends-Roots.webp\" alt=\"Ongoing trends of T-cell Immunotherapy. Popular on various social media handles such as twitter reflecting the rising interest among stakeholders\" class=\"wp-image-19398\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/T-Cell-Immunotherapy-Social-Media-Trends-Roots.webp 672w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/T-Cell-Immunotherapy-Social-Media-Trends-Roots-300x188.webp 300w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/T-Cell-Immunotherapy-Social-Media-Trends-Roots-200x125.webp 200w\" sizes=\"auto, (max-width: 672px) 100vw, 672px\" \/><\/figure>\n<\/div>\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>A Robust, Steadily Growing Pipeline:<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Around 280 T-cell therapies are across various development stages. 38% of these are in preclinical \/ discovery \/ early stages of development, indicating a relatively higher long-term promise<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"672\" height=\"376\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/T-Cell-Immunotherapy-Market-Pipeline-Roots.webp\" alt=\"Currently, around 30 CAR-T therapies are used for Non-Hodgkin's Lymphoma\" class=\"wp-image-19399\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/T-Cell-Immunotherapy-Market-Pipeline-Roots.webp 672w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/T-Cell-Immunotherapy-Market-Pipeline-Roots-300x168.webp 300w\" sizes=\"auto, (max-width: 672px) 100vw, 672px\" \/><\/figure>\n<\/div>\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Academia is Bolstering Innovation:<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The early innovation in the field must be credited to the efforts of several research institutes across different regions<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"672\" height=\"442\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/T-Cell-Immunotherapy-Current-Market-Landscape-Roots.webp\" alt=\"Market landscape of various non-industry players based in US, Europe and Rest of the World engaged in CAR-T, TCR and TIL therapies\" class=\"wp-image-19400\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/T-Cell-Immunotherapy-Current-Market-Landscape-Roots.webp 672w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/T-Cell-Immunotherapy-Current-Market-Landscape-Roots-300x197.webp 300w\" sizes=\"auto, (max-width: 672px) 100vw, 672px\" \/><\/figure>\n<\/div>\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Partnerships are Commonplace:<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">A number of strategic alliances have been forged in order to advance the development of different product candidates<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"672\" height=\"375\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/T-Cell-Immunotherapy-Partnership-Alliances-Roots.webp\" alt=\"Majority, of the partnerships were inked by various industry and non-industry players were focused on UCART\" class=\"wp-image-19403\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/T-Cell-Immunotherapy-Partnership-Alliances-Roots.webp 672w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/T-Cell-Immunotherapy-Partnership-Alliances-Roots-300x167.webp 300w\" sizes=\"auto, (max-width: 672px) 100vw, 672px\" \/><\/figure>\n<\/div>\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Extensive Venture Capital Support:<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Backed by enormous VC funding, the pace of research is unlikely to subside<\/p>\n\n\n<div class=\"wp-block-image\">\n<figure class=\"aligncenter size-full\"><img loading=\"lazy\" decoding=\"async\" width=\"672\" height=\"362\" src=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/T-Cell-Immunotherapy-Funding-Instances-Roots-1.webp\" alt=\"Various stakeholders are currently investing in T-cell immunotherapy. It is worth highlighting that over 20% of the funding were raised through Venture Series A round. \" class=\"wp-image-19402\" srcset=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/T-Cell-Immunotherapy-Funding-Instances-Roots-1.webp 672w, https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2023\/10\/T-Cell-Immunotherapy-Funding-Instances-Roots-1-300x162.webp 300w\" sizes=\"auto, (max-width: 672px) 100vw, 672px\" \/><\/figure>\n<\/div>\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>A USD 25 billion+ future:<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">With several promising candidates and encouraging <a href=\"https:\/\/en.wikipedia.org\/wiki\/Cancer_immunotherapy\">clinical outcomes<\/a>, the industry is gradually moving towards a lucrative multi-billion dollar future.<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Start-ups to Watch Out for (Indicative List):<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Altor BioScience, Autolus, Adicet Bio, Catapult Therapy TCR, Chimeric Therapeutics, Formula Pharmaceuticals, Gadeta, Immatics US, JW Biotechnology, Lion TCR, Leucid Bio, Mustang Therapeutics, Poseida Therapeutics, TILT Biotherapeutics, TNK Therapeutics, Tmunity Therapeutics and Vor Biopharma<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Potential Blockbuster Therapies (Indicative List):<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>&nbsp;<\/strong>KTE-C19, CTL019, NY-ESO-1 TCR, ALT 801 and JCAR017<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Specific Pockets of High Growth (Indicative List):<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Variety of novel immunotherapies other than CAR-T, TCR and TIL (example of companies: Atara Biotherapeutics, Cell Medica and Tessa Therapeutics), &nbsp;spin-outs from academia (around 50% of all the therapies currently in the pipeline have involvement of academic institutions) and manufacturing services for T-cell therapies (examples of CMOs: apceth Biopharma, Atlantic Bio GMP, Cell and Gene Therapy Catapult)<\/p>\n\n\n\n<hr class=\"wp-block-separator has-alpha-channel-opacity\"\/>\n\n\n\n<p class=\"wp-block-paragraph\">For more information, please click&nbsp;<span style=\"text-decoration: underline;\"><strong><a href=\"https:\/\/www.rootsanalysis.com\/reports\/view_document\/t-cell-immunotherapy-market-2nd-edition-2017-2030\/151.html\">T-cell immunotherapy Market (2nd Edition), 2017-2030<\/a><\/strong><\/span>. For any queries \/ suggestions or if you\u2019d like to get access to the full research results, please do not hesitate to contact us <span style=\"text-decoration: underline;\"><strong><a href=\"mailto:sales@rootsanalysis.com\">sales@rootsanalysis.com<\/a><\/strong><\/span>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The concept of immunotherapies dates back to the 18th century; however, since its inception, the field has evolved tremendously&nbsp;and is currently cited as one of the most rapidly growing segments of the pharmaceutical industry. Post the early success of immune checkpoint inhibitors, T-cell immunotherapy has emerged as another innovative and potent arm of this market. [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":11929,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[86,66],"tags":[54,56,70],"class_list":["post-8513","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-immunotherapy","category-pharmaceuticals","tag-future-medicine","tag-personalized-medicine","tag-pharmaceutical-market"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>T-Cell Immunotherapy: The Next Big Thing in Immunotherapy<\/title>\n<meta name=\"description\" content=\"The &#039;T-Cell Immunotherapy Market, 2017-2030 (2nd edition)&#039;\u00a0report features an extensive study of the current market landscape and the..\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rootsanalysis.com\/blog\/t-cell-immunotherapy-the-next-big-thing-in-immunotherapeutics\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"T-Cell Immunotherapy: The Next Big Thing in Immunotherapy\" \/>\n<meta property=\"og:description\" content=\"The &#039;T-Cell Immunotherapy Market, 2017-2030 (2nd edition)&#039;\u00a0report features an extensive study of the current market landscape and the..\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rootsanalysis.com\/blog\/t-cell-immunotherapy-the-next-big-thing-in-immunotherapeutics\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RootsAnalysis\/\" \/>\n<meta property=\"article:published_time\" content=\"2017-08-02T07:36:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-09T09:58:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2017\/08\/pexels-photo-356040.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"500\" \/>\n\t<meta property=\"og:image:height\" content=\"333\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Arun Gupta\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@RootsAnalysis\" \/>\n<meta name=\"twitter:site\" content=\"@RootsAnalysis\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Arun Gupta\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/t-cell-immunotherapy-the-next-big-thing-in-immunotherapeutics\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/t-cell-immunotherapy-the-next-big-thing-in-immunotherapeutics\\\/\"},\"author\":{\"name\":\"Arun Gupta\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/person\\\/af9198bf467c6e126793d9da458a1f62\"},\"headline\":\"T-Cell Immunotherapy: The Next Big Thing in Immunotherapeutics\",\"datePublished\":\"2017-08-02T07:36:32+00:00\",\"dateModified\":\"2026-07-09T09:58:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/t-cell-immunotherapy-the-next-big-thing-in-immunotherapeutics\\\/\"},\"wordCount\":391,\"publisher\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/t-cell-immunotherapy-the-next-big-thing-in-immunotherapeutics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2017\\\/08\\\/pexels-photo-356040.jpeg\",\"keywords\":[\"Future Medicine\",\"Personalized Medicine\",\"Pharmaceutical Market\"],\"articleSection\":[\"Immunotherapy\",\"Pharmaceuticals\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/t-cell-immunotherapy-the-next-big-thing-in-immunotherapeutics\\\/\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/t-cell-immunotherapy-the-next-big-thing-in-immunotherapeutics\\\/\",\"name\":\"T-Cell Immunotherapy: The Next Big Thing in Immunotherapy\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/t-cell-immunotherapy-the-next-big-thing-in-immunotherapeutics\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/t-cell-immunotherapy-the-next-big-thing-in-immunotherapeutics\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2017\\\/08\\\/pexels-photo-356040.jpeg\",\"datePublished\":\"2017-08-02T07:36:32+00:00\",\"dateModified\":\"2026-07-09T09:58:37+00:00\",\"description\":\"The 'T-Cell Immunotherapy Market, 2017-2030 (2nd edition)'\u00a0report features an extensive study of the current market landscape and the..\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/t-cell-immunotherapy-the-next-big-thing-in-immunotherapeutics\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/t-cell-immunotherapy-the-next-big-thing-in-immunotherapeutics\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/t-cell-immunotherapy-the-next-big-thing-in-immunotherapeutics\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2017\\\/08\\\/pexels-photo-356040.jpeg\",\"contentUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2017\\\/08\\\/pexels-photo-356040.jpeg\",\"width\":500,\"height\":333,\"caption\":\"Rootsanalysis\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/t-cell-immunotherapy-the-next-big-thing-in-immunotherapeutics\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"T-Cell Immunotherapy: The Next Big Thing in Immunotherapeutics\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\",\"name\":\"Blog\",\"description\":\"Roots Analysis\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#organization\",\"name\":\"Roots Analysis\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/Roots-Analysis-High-Resolution-Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/wp-content\\\/uploads\\\/2018\\\/11\\\/Roots-Analysis-High-Resolution-Logo.jpg\",\"width\":205,\"height\":61,\"caption\":\"Roots Analysis\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RootsAnalysis\\\/\",\"https:\\\/\\\/x.com\\\/RootsAnalysis\",\"https:\\\/\\\/www.instagram.com\\\/rootsanalysis\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/roots-analysis\\\/\",\"https:\\\/\\\/www.pinterest.it\\\/analysis1340\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCwZF57vY1lnU0bNLej2zukg\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.rootsanalysis.com\\\/blog\\\/#\\\/schema\\\/person\\\/af9198bf467c6e126793d9da458a1f62\",\"name\":\"Arun Gupta\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g\",\"caption\":\"Arun Gupta\"},\"description\":\"Arun is an enthusiastic professional and has been associated with Roots Analysis since the very early years. He has led multifaceted roles over the years be it business research, consulting, competitive intelligence, IT &amp; technology, sales and marketing. He currently drives strategic thinking and execution within the sales and marketing domain. With educational background in life sciences from Thapar University and digital marketing credentials from Indian School of Business, he has led a lot of critical initiatives at the organization. His background in life sciences has been one of the key reasons for quick understanding and implementation of customized marketing strategies. During his early years, he has led multiple consulting assignments for global clients ranging from competitive landscaping, deal structuring and preparing go-to-market strategy for his clients.\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"T-Cell Immunotherapy: The Next Big Thing in Immunotherapy","description":"The 'T-Cell Immunotherapy Market, 2017-2030 (2nd edition)'\u00a0report features an extensive study of the current market landscape and the..","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rootsanalysis.com\/blog\/t-cell-immunotherapy-the-next-big-thing-in-immunotherapeutics\/","og_locale":"en_US","og_type":"article","og_title":"T-Cell Immunotherapy: The Next Big Thing in Immunotherapy","og_description":"The 'T-Cell Immunotherapy Market, 2017-2030 (2nd edition)'\u00a0report features an extensive study of the current market landscape and the..","og_url":"https:\/\/www.rootsanalysis.com\/blog\/t-cell-immunotherapy-the-next-big-thing-in-immunotherapeutics\/","og_site_name":"Blog","article_publisher":"https:\/\/www.facebook.com\/RootsAnalysis\/","article_published_time":"2017-08-02T07:36:32+00:00","article_modified_time":"2026-07-09T09:58:37+00:00","og_image":[{"width":500,"height":333,"url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2017\/08\/pexels-photo-356040.jpeg","type":"image\/jpeg"}],"author":"Arun Gupta","twitter_card":"summary_large_image","twitter_creator":"@RootsAnalysis","twitter_site":"@RootsAnalysis","twitter_misc":{"Written by":"Arun Gupta","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.rootsanalysis.com\/blog\/t-cell-immunotherapy-the-next-big-thing-in-immunotherapeutics\/#article","isPartOf":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/t-cell-immunotherapy-the-next-big-thing-in-immunotherapeutics\/"},"author":{"name":"Arun Gupta","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/person\/af9198bf467c6e126793d9da458a1f62"},"headline":"T-Cell Immunotherapy: The Next Big Thing in Immunotherapeutics","datePublished":"2017-08-02T07:36:32+00:00","dateModified":"2026-07-09T09:58:37+00:00","mainEntityOfPage":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/t-cell-immunotherapy-the-next-big-thing-in-immunotherapeutics\/"},"wordCount":391,"publisher":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/t-cell-immunotherapy-the-next-big-thing-in-immunotherapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2017\/08\/pexels-photo-356040.jpeg","keywords":["Future Medicine","Personalized Medicine","Pharmaceutical Market"],"articleSection":["Immunotherapy","Pharmaceuticals"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.rootsanalysis.com\/blog\/t-cell-immunotherapy-the-next-big-thing-in-immunotherapeutics\/","url":"https:\/\/www.rootsanalysis.com\/blog\/t-cell-immunotherapy-the-next-big-thing-in-immunotherapeutics\/","name":"T-Cell Immunotherapy: The Next Big Thing in Immunotherapy","isPartOf":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/t-cell-immunotherapy-the-next-big-thing-in-immunotherapeutics\/#primaryimage"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/t-cell-immunotherapy-the-next-big-thing-in-immunotherapeutics\/#primaryimage"},"thumbnailUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2017\/08\/pexels-photo-356040.jpeg","datePublished":"2017-08-02T07:36:32+00:00","dateModified":"2026-07-09T09:58:37+00:00","description":"The 'T-Cell Immunotherapy Market, 2017-2030 (2nd edition)'\u00a0report features an extensive study of the current market landscape and the..","breadcrumb":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/t-cell-immunotherapy-the-next-big-thing-in-immunotherapeutics\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rootsanalysis.com\/blog\/t-cell-immunotherapy-the-next-big-thing-in-immunotherapeutics\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rootsanalysis.com\/blog\/t-cell-immunotherapy-the-next-big-thing-in-immunotherapeutics\/#primaryimage","url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2017\/08\/pexels-photo-356040.jpeg","contentUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2017\/08\/pexels-photo-356040.jpeg","width":500,"height":333,"caption":"Rootsanalysis"},{"@type":"BreadcrumbList","@id":"https:\/\/www.rootsanalysis.com\/blog\/t-cell-immunotherapy-the-next-big-thing-in-immunotherapeutics\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.rootsanalysis.com\/blog\/"},{"@type":"ListItem","position":2,"name":"T-Cell Immunotherapy: The Next Big Thing in Immunotherapeutics"}]},{"@type":"WebSite","@id":"https:\/\/www.rootsanalysis.com\/blog\/#website","url":"https:\/\/www.rootsanalysis.com\/blog\/","name":"Blog","description":"Roots Analysis","publisher":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rootsanalysis.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.rootsanalysis.com\/blog\/#organization","name":"Roots Analysis","url":"https:\/\/www.rootsanalysis.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/11\/Roots-Analysis-High-Resolution-Logo.jpg","contentUrl":"https:\/\/www.rootsanalysis.com\/blog\/wp-content\/uploads\/2018\/11\/Roots-Analysis-High-Resolution-Logo.jpg","width":205,"height":61,"caption":"Roots Analysis"},"image":{"@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RootsAnalysis\/","https:\/\/x.com\/RootsAnalysis","https:\/\/www.instagram.com\/rootsanalysis\/","https:\/\/www.linkedin.com\/company\/roots-analysis\/","https:\/\/www.pinterest.it\/analysis1340\/","https:\/\/www.youtube.com\/channel\/UCwZF57vY1lnU0bNLej2zukg"]},{"@type":"Person","@id":"https:\/\/www.rootsanalysis.com\/blog\/#\/schema\/person\/af9198bf467c6e126793d9da458a1f62","name":"Arun Gupta","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/f9986f38d8b0d52644107e8fa0c7a9752d6b1c008a202226542b78eab3cd1771?s=96&d=mm&r=g","caption":"Arun Gupta"},"description":"Arun is an enthusiastic professional and has been associated with Roots Analysis since the very early years. He has led multifaceted roles over the years be it business research, consulting, competitive intelligence, IT &amp; technology, sales and marketing. He currently drives strategic thinking and execution within the sales and marketing domain. With educational background in life sciences from Thapar University and digital marketing credentials from Indian School of Business, he has led a lot of critical initiatives at the organization. His background in life sciences has been one of the key reasons for quick understanding and implementation of customized marketing strategies. During his early years, he has led multiple consulting assignments for global clients ranging from competitive landscaping, deal structuring and preparing go-to-market strategy for his clients."}]}},"_links":{"self":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/8513","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/users\/8"}],"replies":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/comments?post=8513"}],"version-history":[{"count":4,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/8513\/revisions"}],"predecessor-version":[{"id":22473,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/posts\/8513\/revisions\/22473"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/media\/11929"}],"wp:attachment":[{"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/media?parent=8513"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/categories?post=8513"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rootsanalysis.com\/blog\/wp-json\/wp\/v2\/tags?post=8513"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}